Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
19 Jun 2024 - Joe David, Managing Director of Elementos discusses the company's recent exciting discovery of high-grade copper and gold at the Cleveland Tin Project in Tasmania. Joe provides insights into the implications of this find, the project's background, and future exploration plans.
Read More17 Dec 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the funding package and resumption plan for the Granville Tin Project and plans for Granville to be a foundation asset in a proposed IPO.
Read More20 Feb 2024 - ABx Group: Pioneering rare earths exploration, fluoride breakthroughs, and bauxite triumphs in Tasmania.
Read More20 Jul 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO Giles Bourne gives an update on the commissioning of the BLG 500 at Silverwater, strategic alliances and product roadmap.
Read More14 July 2023 - Shaw and Partners Chief Investment Officer Martin Crabb takes a look at the current economic situation and what it means for portfolios and investments going forward.
Read More12 Mar 2025 - Sofdra's rollout and the path to $100m revenue
Read More30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
Read More20 Sep 2019 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack provides an update on the company's Arcadia lithium project in Zimbabwe, including advanced negotiations with a number of African and international banks on funding.
Read More18 Apr 2024 - Anax Metals (ASX:ANX) CEO Geoff Laing discusses the company's innovative approach to mining as its pioneers bioleaching tech for sustainable resource extraction.
Read More04 Oct 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY22 highlights, revenue drivers, growth investments, hybrid working tailwinds and the outlook for FY23.
Read More
